Stockscreener 앱 받기
23.61
3.55%
0.81
시간 외 거래:
23.61
전일 마감가:
$22.80
열려 있는:
$22.68
하루 거래량:
2.23M
Relative Volume:
2.11
시가총액:
$3.03B
수익:
$2.89B
순이익/손실:
$-33.80M
주가수익비율:
-87.44
EPS:
-0.27
순현금흐름:
$204.10M
1주 성능:
+3.55%
1개월 성능:
+5.73%
6개월 성능:
-0.96%
1년 성능:
-13.45%
1일 변동 폭
$22.66
$24.04
1주일 범위
$22.66
$24.04
52주 변동 폭
$19.50
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
명칭
Surgery Partners Inc
전화
615-234-5900
주소
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
SGRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
23.61 | 2.92B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
381.39 | 90.60B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
168.77 | 15.14B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.90 | 11.98B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
190.35 | 12.00B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
136.26 | 10.44B | 12.82B | 936.34M | 1.47B | 10.74 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-16 | 개시 | BofA Securities | Buy |
| 2024-10-14 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | 개시 | Macquarie | Outperform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-11-14 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-05-12 | 개시 | Mizuho | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-11-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-06-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-01-10 | 재개 | Citigroup | Buy |
| 2021-11-30 | 개시 | Barclays | Overweight |
| 2021-11-29 | 업그레이드 | Stifel | Hold → Buy |
| 2021-11-01 | 개시 | JP Morgan | Neutral |
| 2021-10-18 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-06-23 | 재개 | Stifel | Hold |
| 2020-09-17 | 재확인 | The Benchmark Company | Buy |
| 2020-04-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-03-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-01-14 | 재확인 | The Benchmark Company | Buy |
| 2018-11-16 | 개시 | UBS | Neutral |
| 2018-09-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | 업그레이드 | Stifel | Sell → Hold |
| 2018-01-30 | 재확인 | The Benchmark Company | Buy |
| 2017-11-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | 다운그레이드 | Stifel | Hold → Sell |
| 2017-04-24 | 재확인 | Stifel | Hold |
| 2017-03-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2017-01-31 | 개시 | The Benchmark Company | Buy |
| 2016-06-10 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-10-27 | 개시 | Stifel | Buy |
| 2015-10-26 | 개시 | RBC Capital Mkts | Outperform |
| 2015-10-26 | 개시 | Raymond James | Strong Buy |
모두보기
Surgery Partners Inc 주식(SGRY)의 최신 뉴스
Surgery Partners Inc (SGRY) Trading 4.94% Higher on May 30 - GuruFocus
Cantor Fitzgerald maintains Overweight on Surgery Partners shares By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Surgery Partners shares - Investing.com
Assessing Surgery Partners: Insights From 4 Financial Analysts - Benzinga
Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT - MSN
Surgery Partners (SGRY) Target Price Lowered by Barclays | SGRY Stock News - GuruFocus
Surgery Partners price target lowered to $24 from $25 at Barclays - TipRanks
Surgery Partners (SGRY) Faces Price Target Reduction by Barclays | SGRY Stock News - GuruFocus
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Q1 Earnings Highlights: Surgery Partners (NASDAQ:SGRY) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
Surgery Partners gains amid report of AMSURG sale process - MSN
Surgery Partners (SGRY) Shares Climb Amid AMSURG Sale Speculatio - GuruFocus
Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth - MSN
Surgery Partners stock gains amid report of AMSURG sale process - Seeking Alpha
Decoding Surgery Partners Inc (SGRY): A Strategic SWOT Insight - GuruFocus
Commit To Purchase Surgery Partners At $20, Earn 30.4% Annualized Using Options - Nasdaq
Investor Network: Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Northern Trust Corp Acquires 15,657 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
The Manufacturers Life Insurance Company Decreases Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners stock holds Buy rating, $35 target from Benchmark By Investing.com - Investing.com Canada
Leerink cuts Surgery Partners target to $34, keeps Outperform rating By Investing.com - Investing.com Nigeria
Leerink cuts Surgery Partners target to $34, keeps Outperform rating - Investing.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Call Transcript - Insider Monkey
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: St - GuruFocus
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Surgery Partners (SGRY) Misses Q1 Earnings Expectations - GuruFocus
Surgery Partners (SGRY) Reports Q1 2025 Growth in Revenue and Su - GuruFocus
Surgery Partners Reports Q1 Revenue Growth and Reaffirms 2025 Outlook - TipRanks
Surgery Partners Inc. Reports Strong Growth Amid Challenges - TipRanks
Surgery Partners Inc Reports Q1 2025 Results: EPS Misses at -$0. - GuruFocus
Surgery Partners: Q1 Earnings Snapshot - MySA
Surgery Partners Misses Q1 Marks But Sticks To 2025 OutlookSurgery Partners (NASDAQ:SGRY) - Benzinga
Surgery Partners Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Earnings call transcript: Surgery Partners Q1 2025 results show mixed performance - Investing.com
Surgery Partners Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Surgery Partners Reaffirms FY25 OutlookUpdate - Nasdaq
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates - Yahoo Finance
Surgery Partners, Inc. Announces First Quarter 2025 Results; Rea - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Perfor - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Performance | SGRY Stock News - GuruFocus
Why Surgery Partners Stock is Under Pressure - TipRanks
(SGRY) Surgery Partners Expects 2025 Revenue Range $3.3B$3.45B, vs. FactSet Est of $3.39B - marketscreener.com
Earnings Flash (SGRY) Surgery Partners Posts Q1 Revenue $776M, vs. FactSet Est of $777.3M - marketscreener.com
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance - The Manila Times
Surgery Partners (NASDAQ:SGRY) Posts Q1 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Surgery Partners Inc (SGRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.87%
자본화:
|
볼륨(24시간):